Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Monoclonal Antibodies Directed to a Disulfated Glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), Associated with Human Hepatocellular Carcinoma

Nozomu Hiraiwa, Naoko Iida, Ineo Ishizuka, Shigeyuki Itai, Katsuyoshi Shigeta, Reiji Kannagi, Yoshihiro Fukuda and Hiroo Imura
Nozomu Hiraiwa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoko Iida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ineo Ishizuka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeyuki Itai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuyoshi Shigeta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reiji Kannagi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Fukuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroo Imura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published December 1988
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Two murine monoclonal antibodies, 2H6G5 (IgM) and 4A9E10 (IgG3), were obtained by using either cultured human hepatocellular carcinoma cells (PLC/PRF/5) or the acidic glycolipid mixture prepared from the same cells as immunogens. The antigen in PLC/PRF/5 cell membranes recognized by both antibodies was identified as a disulfated acidic glycolipid, GgOse4Cer-II3IV3-bis-sulfate (SB1a). Both antibodies reacted specifically with SB1a, and no significant reactivity was noted with other sulfated glycolipids or gangliosides except that the antibody 2H6G5 showed a weak cross-reactivity with LacCer-II3-sulfate (SM3), another sulfated glycolipid which partly shares the same carbohydrate structure as SB1a. The SB1a antigen is a relatively minor glycolipid in PLC/PRF/5 cells, but it was strongly expressed at the surface of PLC/PRF/5 cells as ascertained by cytofluorometry using both antibodies. A significant amount of SB1a antigen was present in 3 of the acidic glycolipid fractions isolated from 15 human hepatocellular carcinoma tissues as well as in the acidic glycolipid fraction prepared from PLC/PRF/5 cells, while all the acidic glycolipid fractions prepared from cirrhotic livers and a normal liver were essentially negative for SB1a, as ascertained by both solid phase enzyme immunoassay and the thin-layer chromatography-immunostaining method. These results strongly suggest that the SB1a antigen as defined by these new monoclonal antibodies is associated with human hepatocellular carcinoma.

Footnotes

  • ↵1 This work was supported in part by a grant-in-aid for Cancer Research from the Ministry of Education, Science and Culture, Japan, and grants-in-aid from the Japanese Foundation for Multidisciplinary Treatment of Cancer, the Uehara Memorial Foundation, and the Princess Takamatsu Cancer Research Foundation, to R. K.

  • ↵2 To whom requests for reprints should be addressed.

  • Received April 19, 1988.
  • Revision received August 5, 1988.
  • Accepted August 11, 1988.
  • ©1988 American Association for Cancer Research.
PreviousNext
Back to top
December 1988
Volume 48, Issue 23
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Monoclonal Antibodies Directed to a Disulfated Glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), Associated with Human Hepatocellular Carcinoma
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Monoclonal Antibodies Directed to a Disulfated Glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), Associated with Human Hepatocellular Carcinoma
Nozomu Hiraiwa, Naoko Iida, Ineo Ishizuka, Shigeyuki Itai, Katsuyoshi Shigeta, Reiji Kannagi, Yoshihiro Fukuda and Hiroo Imura
Cancer Res December 1 1988 (48) (23) 6769-6774;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Monoclonal Antibodies Directed to a Disulfated Glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), Associated with Human Hepatocellular Carcinoma
Nozomu Hiraiwa, Naoko Iida, Ineo Ishizuka, Shigeyuki Itai, Katsuyoshi Shigeta, Reiji Kannagi, Yoshihiro Fukuda and Hiroo Imura
Cancer Res December 1 1988 (48) (23) 6769-6774;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • Forestomach and Kidney Carcinogenicity of Caffeic Acid in F344 Rats and C57BL/6N × C3H/HeN F1 Mice
  • Glucocorticoid Insensitivity of P1798 Lymphoma Cells Is Associated with Production of a Factor That Attenuates the Lytic Response
  • Immunohistochemical and Pharmacokinetic Characterization of Site-specific Immunoconjugate 15A8-Glycyl-tyrosyl-(N-ε-diethylenetriamine Pentaacetic Acid)-lysine Derived from Anti-Breast Carcinoma Monoclonal Antibody 15A8
Show more Basic Sciences

Articles

  • Membership of Awards Assembly
  • Genetic Control of Programmed Cell Death in the Nematode Caenorhabditis elegans
  • BRCA1, BRCA2, and Rad51 Operate in a Common DNA Damage Response Pathway
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement